Advances in understanding the aetiology of atypical Haemolytic Uraemic Syndrome

British Journal of Haematology

Volumn 150, Issue 5, 2010, Pages 529-542

  Sánchez Corral, Pilar ^a,b   Melgosa, Marta ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

Author keywords

anti factor H autoantibodies; complement system; Haemolytic Uraemic Syndrome; plasma therapy; transplantation

Indexed keywords

ACETYLSALICYLIC ACID; ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; AUTOANTIBODY; COMPLEMENT; COMPLEMENT COMPONENT C3; COMPLEMENT FACTOR H; FIBRINOGEN; LOW MOLECULAR WEIGHT HEPARIN; MEMBRANE COFACTOR PROTEIN; RITUXIMAB; THROMBOMODULIN;

ATYPICAL HEMOLYTIC UREMIC SYNDROME; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; GENE MUTATION; GENETICS; HEMOLYTIC UREMIC SYNDROME; HEREDITY; HUMAN; KIDNEY TRANSPLANTATION; MOLECULAR DYNAMICS; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; REGULATORY MECHANISM; REVIEW; GENETIC PREDISPOSITION; HEMOLYTIC-UREMIC SYNDROME; IMMUNOLOGY; MUTATION;

COMPLEMENT PATHWAY, ALTERNATIVE; GENETIC PREDISPOSITION TO DISEASE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; KIDNEY TRANSPLANTATION; MUTATION;

EID: 77955779512     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08295.x     Document Type: Review

References (84)

1. Abarrategui-Garrido, C., Melgosa, M., Peña-Carrión, A., Goicoechea de Jorge, E., Rodríguez de Córdoba, S., López -Trascasa, M. Sánchez- Corral, P. (2008) Mutations in proteins of the alternative pathway of complement and the pathogenesis of atypical hemolytic uremic syndrome. American Journal of Kidney Disease, 52, 171 180.
2. Abarrategui-Garrido, C., Martínez-Barricarte, R., López-Trascasa, M., Rodríguez de Córdoba, S. Sánchez-Corral, P. (2009) Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome. Blood, 114, 4261 4271.
3. Ariceta, G., Besbas, N., Johnson, S., Karpman, D., Landau, D., Licht, C., Loirat, Ch., Pecoraro, C., Taylor, M., Van de Kar, N., VandeWalle, J. Zimmerhackl, L.B. for The European Paediatric Study Group for HUS (2009) Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome. Pediatric Nephrology, 24, 687 696.
4. Bienaime, F., Dragon-Durey, M.A., Regnier, C.H., Nilsson, S.C., Kwan, W.H., Blouin, J., Jablonski, M., Renault, N., Rameix-Welti, M.A., Loirat, C., Sautés-Fridman, C., Villoutreix, B.O., Blom, A.M. Fremeaux-Bacchi, V. (2010) Mutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome. Kidney Internatonal, 77, 339 349.
5. Blom, A.M., Bergström, F., Edey, M., Diaz-Torres, M., Kavanagh, D., Lampe, A., Goodship, J.A., Strain, L., Moghal, N., McHugh, M., Inward, C., Tomson, C., Frémeaux-Bacchi, V., Villoutreix, B.O. Goodship, T.H. (2008) A novel non-synonymous polymorphism (p.Arg240His) in C4b-binding protein is associated with atypical hemolytic uremic syndrome and leads to impaired alternative pathway cofactor activity. Journal of Immunology, 180, 6385 6391.
6. Boyer, O., Balzamo, E., Charbit, M., Biebuyck-Gougé, N., Salomon, R., Dragon-Durey, M.A., Frémeaux-Bacchi, V. Niaudet, P. (2010) Pulse cyclophosphamide therapy and clinical remission in Atypical Hemolytic Uremic Syndrome with Anti-Complement factor H Autoantibodies. American Journal of Kidney Diseases, 55, 923 927.
7. Caprioli, J., Bettinaglio, P., Zipfel, P.F., Amadei, B., Daina, E., Gamba, S., Skerka, C., Marziliano, N., Remuzzi, G. Noris, M. (2001) The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20. Journal of the American Society of Nephrology, 12, 297 307.
8. Caprioli, J., Castelletti, F., Bucchioni, S., Bettinaglio, P., Bresin, E., Pianetti, G., Gamba, S., Brioschi, A., Daina, E., Remuzzi, G. Noris, M. (2003) Complement factor H mutations and gene polymorphisms in hemolytic uremic syndrome: the c-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease. Human Molecular Genetics, 12, 3385 3395.
9. Caprioli, J., Noris, M., Brioschi, S., Pianetti, G., Castelleti, F., Bettinaglio, P., Mele, C., Bresin, E., Cassis, L., Gamba, S., Porrati, F., Bucchioni, S., Monteferrante, G., Fang, C.J., Liszewski, M.K., Kavanagh, D., Atkinson, J.P., Remuzzi, G. for the International Registry of Recurrent and Familial HUS/TTP (2006) Genetics of HUS: the impact of MCP, CFH and IF mutations on clinical presentation, response to treatment, and outcome. Blood, 108, 1267 1279.
10. Chatelet, V., Frémeaux-Bacchi, V., Lobbedez, T., Ficheux, M. de Ligny, B.H. (2009) Safety and long-term efficacy of eculizumab in a renal transplant patient with recurrent atypical hemolytic-uremic syndrome. American Journal of Transplantation, 9, 2644 2645.
11. Cheong, H.I., Lee, B.S., Kang, H.G., Hahn, H., Suh, K.S., Ha, I.S. Choi, Y. (2004) Attempted treatment of factor H deficiency by liver transplantation. Pediatric Nephrology, 19, 454 458.
12. Couzi, L., Contin-Bordes, C., Marliot, F., Sarrat, A., Grimal, P., Moreau, J.F., Merville, P. Fremeaux-Bacchi, V. (2008) Inherited deficiency of membrane cofactor protein expression and varying manifestations of recurrent atypical hemolytic uremic syndrome in a sibling pair. American Journal of Kidney Diseases, 52, e5 e9.
13. Cruzado, J.M., de Córdoba, S.R., Melilli, E., Bestard, O., Rama, I., Sánchez-Corral, P., López-Trascasa, M., Navarro, I., Torras, J., Gomà, M. Grinyó, J.M. (2009) Successful renal transplantation in a patient with atypical hemolytic uremic syndrome carrying mutations in both factor I and MCP. American Journal of Transplantation, 9, 1477 1483.
14. Davin, J.C., Gracchi, V., Bouts, A., Groothoff, J., Strain, L. Goodship, T. (2010) Maintenance of kidney function following treatment with eculizumab and discontinuation of plasma exchange after a third kidney transplant for atypical hemolytic uremic syndrome associated with a CFH mutation. American Journal of Kidney Diseases, 55, 708 711.
15. Delvaeye, M., Noris, M., De Vriese, A., Esmon, C.T., Esmon, N.L., Ferrell, G., Del-Favero, J., Plaisance, S., Claes, B., Lambrechts, D., Zoja, C., Remuzzi, G. Conway, E.M. (2009) Thrombomodulin mutations in atypical hemolytic-uremic syndrome. The New England Journal of Medicine, 361, 345 357.
16. Donne, R.L., Abbs, I., Barany, P., Elinder, C.G., Little, M., Conlon, P. Goodship, T.H. (2002) Recurrence of hemolytic uremic syndrome after live related renal transplantation associated with subsequent de novo disease in the donor. American Journal of Kidney Disease, 40, E22.
17. Dragon-Durey, M.A., Frémeaux-Bacchi, V., Loirat, C., Blouin, J., Niaudet, P., Deschenes, G., Coppo, P., Herman Fridman, W. Weiss, L. (2004) Heterozygous and homozygous Factor H deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: report and genetic analysis of 16 cases. Journal of American Society of Nephrology, 15, 787 795.
18. Dragon-Durey, M.A., Loirat, C., Cloarec, S., Macher, M.A., Blouin, J., Nivet, H., Weiss, L., Fridman, W.H. Frémeaux-Bacchi, V. (2005) Anti-factor H autoantibodies associated with atypical hemolytic uremic syndrome. Journal of the American Society of Nephrology, 16, 555 563.
19. Dragon-Durey, M.A., Blanc, C., Marliot, F., Loirat, C., Blouin, J., Sautes-Fridman, C., Fridman, W.H. Frémeaux-Bacchi, V. (2009) The high frequency of complement factor H-related CFHR1 gene deletion is restricted to specific subgroups of patients with atypical haemolytic uraemic syndrome. Journal of Medical Genetics, 46, 447 450.
20. Esparza-Gordillo, J., Goicoechea de Jorge, E., Buil, A., Carreras-Berges, L., López-Trascasa, M., Sánchez-Corral, P. Rodríguez de Córdoba, S. (2005) Predisposition to atypical Hemolytic Uremic Syndrome involves the concurrence of different susceptibility alleles in the Regulators of Complement Activation gene cluster in 1q32. Human Molecular Genetics, 14, 703 712.
21. Esparza-Gordillo, J., Goicoechea de Jorge, E., Abarrategui-Garrido, C., Carreras, L., López-Trascasa, M., Sánchez-Corral, P. Rodríguez de Córdoba, S. (2006) Insights into hemolytic uremic syndrome: segregation of three independent predisposition factors in a large, multiple affected pedigree. Molecular Immunology, 43, 1769 1775.
22. Fang, C.J., Richards, A., Liszewsky, M.K., Kavanagh, D. Atkinson, J.P. (2008) Advances in understanding of pathogenesis of aHUS and HELLP. British Journal of Haematology, 143, 336 348.
23. Frémeaux Bacchi, V., Dragon-Durey, M.A., Blouin, J., Vigneau, C., Kuypers, D., Boudailliez, B., Loirat, C., Rondeau, E. Fridman, W.H. (2004) Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome. Journal of Medical Genetics, 41, e84 (Online mutation report)
24. Frémeaux- Bacchi, V., Arzouk, N., Ferlicot, S., Charpentier, B., Snanoudj, R. Dürrbach, A. (2007) Recurrence of HUS due to CD46/MCP mutation alter renal transplantation: a role for endothelial microchimerism. American Journal of Transplantation, 7, 2047 2051.
25. Frémeaux-Bacchi, V., Kemp, E.J., Goodship, J.A., Dragon-Durey, M.A., Strain, L., Loirat, C., Deng, H.W. Goodship, T.H. (2005) The development of atypical haemolytic-uraemic syndrome is influenced by susceptibility factors in factor H and membrane cofactor protein: evidence from two independent cohorts. Journal of Medical Genetics, 42, 852 856.
26. Frémeaux-Bacchi, V., Moulton, E.A., Kavanagh, D., Dragon-Durey, M.A., Blouin, J., Caudy, A., Arzouk, N., Cleper, R., Francois, M., Guest, G., Pourrat, J., Seligman, R., Fridman, W.H., Loirat, C. Atkinson, J.P. (2006) Genetic and Functional Analyses of Membrane Cofactor Protein (CD46) Mutations in Atypical Hemolytic Uremic Syndrome. Journal of the American Society of Nephrology, 17, 2017 2025.
27. Frémeaux-Bacchi, V., Miller, E.C., Liszewski, M.K., Strain, L., Blouin, J., Brown, A.L., Moghal, N., Kaplan, B.S., Weiss, R.A., Lhotta, K., Kapur, G., Mattoo, T., Nivet, H., Wong, W., Gie, S., Hurault de Ligny, B., Fischbach, M., Gupta, R., Hauhart, R., Meunier, V., Loirat, C., Dragon-Durey, M.A., Fridman, W.H., Janssen, B.J.C., Goodship, T.H.J. Atkinson, J.P. (2008) Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome. Blood, 112, 4948 4952.
28. Goicoechea de Jorge, E., Harris, C.L., Esparza-Gordillo, J., Carreras, L., Aller Arranz, E., Abarrategui Garrido, C., López-Trascasa, M., Sánchez-Corral, P., Morgan, B.P. Rodríguez de Córdoba, S. (2007) Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome. Proceedings of the National Academy of Sciences of the United States of America, 104, 240 245.
29. Gruppo, R.A. Rother, R.P. (2009) Eculizumab for congenital atypical hemolytic-uremic syndrome. New England Journal of Medicine, 360, 544 546.
30. Heinen, S., Sanchez-Corral, P., Jackson, M.S., Strain, L., Goodship, J.A., Kemp, E.J., Skerka, C., Jokiranta, T.S., Meyers, K., Wagner, E., Robitaille, P., Esparza-Gordillo, J., Rodriguez de Cordoba, S., Zipfel, P.F. Goodship, T.H. (2006) De novo gene conversion in the RCA gene cluster (1q32) causes mutations in complement fH associated with atypical hemolytic uremic syndrome. Human Mutation, 27, 292 293.
31. Jalanko, H., Peltonen, S., Koskinen, A., Puntila, J., Isoniemi, H., Holmberg, C., Pinomaki, A., Armstrong, E., Koivusalo, A., Tukiainen, E., Makisalo, H., Saland, J., Remuzzi, G., de Cordoba, S., Lassila, R. Meri S, Jokiranta.T.S. (2008) Successful liver-kidney transplantation in two children with aHUS caused by a mutation in complement factor H. American Journal of Transplantation, 8, 216 221.
32. Józsi, M. Zipfel, P.F. (2008) Factor H family proteins and human diseases. Trends in Immunology, 29, 380 387.
33. Józsi, M., Strobel, S., Dahse, H.M., Liu, W., Hoyer, P.F., Oppermann, M., Skerka, C. Zipfel, P.F. (2007) Anti-factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome. Blood, 110, 1516 1518.
34. Józsi, M., Licht, C., Strobel, S., Zipfel, S.L.H., Richter, H., Heinen, S., Zipfel, P.F. Skerka, C. (2008) Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency. Blood, 111, 1512 1514. (Pubitemid 351213440)
35. Kavanagh, D., Kemp, E.J., Mayland, E., Winney, R.J., Duffield, J.S., Warwick, G., Richards, A., Ward, R., Goodship, J.A. Goodship, T.H. (2005) Mutations in complement Factor I predispose to development of atypical Hemolytic Uremic Syndrome. Journal of the American Society of Nephrology, 16, 2150 2155.
36. Kavanagh, D., Richards, A., Noris, M., Hauhart, R., Liszewski, M.K., Karpman, D., Goodship, J.A., Fremeaux-Bacchi, V., Remuzzi, G., Goodship, T.H. Atkinson, J.P. (2008) Characterization of mutations in complement factor I (CFI) associated with hemolytic uremic syndrome. Molecular Immunology, 45, 95 105. (Pubitemid 47336973)
37. Kwon, T., Dragon-Durey, M.-A., Macher, M.A., Baudouin, V., Maisin, A., Peuchmaur, M., Fremeaux-Bacchi, V. Loirat, C. (2008) Successful pre-transplant management of a patient with anti-factor H autoantibodies-associated haemolytic uraemic syndrome. Nephrology Dialysis and Transplantation, 23, 2088 2090.
38. Le Quintrec, M., Zuber, J., Noel, L.H., Thervet, E., Frémeaux- Bacchi, V., Niaudet, P., Fridman, W.H., Legendre, C. Dragon-Durey, M.A. (2009) Anti-Factor H autoantibodies in a fifth renal transplant recipient with atypical hemolytic and uremic syndrome. American Journal of Transplantation, 9, 1223 1229.
39. Lee, B.H., Kwak, S.H., Shin, J.I., Lee, S.H., Choi, H.J., Kang, H.G., Ha, I.S., Lee, J.S., Dragon-Durey, M.A., Choi, Y. Cheong, H.I. (2009) Atypical hemolytic uremic syndrome associated with complement factor H autoantibodies and CFHR1/CFHR3 deficiency. Pediatric Research, 66, 336 340.
40. Lhotta, K., Janecke, A.R., Scheiring, J., Petzlberger, B., Giner, T., Fally, V., Würzner, R., Zimmerhackl, L.B., Mayer, G. Fremeaux-Bacchi, V. (2009) A large family with a gain-of-function mutation of complement C3 predisposing to atypical hemolytic uremic syndrome, microhematuria, hypertension and chronic renal failure. Clinical Journal of the American Society of Nephrology, 4, 1356 1362.
41. Lionet, A., Provôt, F., Glowacki, F., Frémeaux-Bacchi, V. Hazzan, M. (2009) A case of adult atypical haemolytic uraemic syndrome related to anti-factor H autoantibodies successfully treated by plasma exchange, corticosteroids and rituximab. Nephrology Dialysis and Transplantation Plus, 2, 458 460.
42. Loirat, C. Frémeaux-Bacchi, V. (2008) Hemolytic uremic syndrome recurrence after renal transplantation. Pediatric Transplantation, 12, 619 629.
43. Mache, C.J., Acham-Roschitz, B., Frémeaux-Bacchi, V., Kirschfink, M., Zipfel, P.F., Roedl, S., Vester, U. Ring, E. (2009) Complement inhibitor eculizumab in atypical hemolytic uremic syndrome. Clinical Journal of the American Society of Nephrology, 4, 1312 1316.
44. Maga, T., Nishimura, C.J., Frees, K.L., Weaver, A. Smith, R.J.H. (2010) Mutations in alternative pathway complement proteins in American patients with atypical Hemolytic Uremic Syndrome. Human Mutation. Mutation in Brief 31 : E1445 E1460.
45. Manuelian, T., Hellwage, J., Meri, S., Caprioli, J., Noris, M., Heinen, S., Jozsi, M., Neumann, H.P., Remuzzi, G. Zipfel, P.F. (2003) Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome. Journal of Clinical Investigation, 111, 1181 1190.
46. Martínez-Barricarte, R., Goicoechea de Jorge, E., Montes, T., Layana, A.G. Rodríguez de Córdoba, S. (2008) Lack of association between polymorphisms in C4b-binding protein and atypical haemolytic uraemic syndrome in the Spanish population. Clinical Experimental Immunology, 155, 59 64.
47. Moore, I., Strain, L., Pappworth, I., Kavanagh, D., Barlow, P.N., Herbert, A.P., Schmidt, C.Q., Staniforth, S.J., Holmes, L.V., Ward, R., Morgan, L., Goodship, T.H.J. Marchbank, K.J. (2010) Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4 and with mutations in CFH, CFI, CD46, and C3 in patients with atypical haemolytic uraemic syndrome. Blood, 115, 379 387.
48. Neumann, H.P., Salzmann, M., Bohnert-Iwan, B., Mannuelian, T., Skerka, C., Lenk, D., Bender, B.U., Cybulla, M., Riegler, P., Königsrainer, A., Neyer, U., Bock, A., Widmer, U., Male, D.A., Franke, G. Zipfel, P.F. (2003) Haemolytic uraemic syndrome and mutations of the factor H gene: a registry-based study of German speaking countries. Journal of Medical Genetics, 40, 676 681.
49. Nilsson, S.C., Kalchishkova, N., Trouw, L.A., Fremeaux-Bacchi, V., Villoutreix, B.O. Blom, A.M. (2010) Mutations in complement factor I as found in atypical hemolytic uremic syndrome lead to either altered secretion or altered function of factor I. European Journal of Immunology, 40, 172 185.
50. Noris, M. Remuzzi, G. (2009) Atypical Hemolytic Uremic Syndrome. New England Journal of Medicine, 361, 1976 1987.
51. Noris, M., Brioschi, S., Caprioli, J., Todeschini, M., Bresin, E., Porrati, F., Gamba, S. Remuzzi, G. (2003) Familial hemolytic uraemic syndrome and an MCP mutation. The Lancet, 362, 1542 1547.
52. Nürnberger, J., Philipp, T., Witzke, O., Opazo Saez, A., Vester, U., Baba, H.A., Kribben, A., Zimmerhackl, L.B., Janecke, A.R., Nagel, M. Kirschfink, M. (2009) Eculizumab for atypical hemolytic-uremic syndrome. New England Journal of Medicine, 360, 542 544.
53. Pérez-Caballero, D., González-Rubio, C., Gallardo, M.E., Vera, M., López-Trascasa, M., Rodríguez de Córdoba, S. Sánchez-Corral, P. (2001) Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome. American Journal of Human Genetics, 68, 478 484.
54. Pichette, V., Quérin, S., Schürch, W., Brun, G., Lehner-Netsch, G. Delâge, J.M. (1994) Familial hemolytic-uremic syndrome and homozygous factor H deficiency. American Journal of Kidney Diseases, 24, 936 941.
55. Pickering, M.C., Cook, H.T., Warren, J., Bygrave, A.E., Moss, J., Walport, M.J. Botto, M. (2002) Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H. Nature Genetics, 31, 424 428.
56. Pickering, M.C., de Jorge, E.G., Martinez-Barricarte, R., Recalde, S., Garcia-Layana, A., Rose, K.L., Moss, J., Walport, M.J., Cook, H.T., de Córdoba, S.R. Botto, M. (2007) Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains. The Journal of Experimental Medicine, 204, 1249 1256.
57. Remuzzi, G., Ruggenenti, P., Codazzi, D., Noris, M., Caprioli, J., Locatelli, G. Gridelli, B. (2002) Combined kidney and liver transplantation for familial haemolytic uraemic syndrome. Lancet, 359, 1671 1672.
58. Remuzzi, G., Ruggenenti, P., Colledan, M., Gridelli, B., Bertani, A., Bettinaglio, P., Bucchioni, S., Sonzogni, A., Bonanomi, E., Sonzogni, V., Platt, J.L., Perico, N. Noris, M. (2005) Hemolytic uremic syndrome: a fatal outcome after kidney and liver transplantation performed to correct factor H gene mutation. American Journal of Transplantation, 5, 1146 1150.
59. Richards, A., Buddles, M.R., Donne, R.L., Kaplan, B.S., Kirk, E., Venning, M.C., Tielemans, C.L., Goodship, J.A. Goodhsip, T.H.J. (2001) Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition. American Journal of Human Genetics, 68, 485 490.
60. Richards, A., Kemp, E.J., Liszewski, M.K., Goodship, J.A., Lampe, A.K., Decorte, R., Müslümanoglu, M.H., Kavuhcu, S., Filler, G., Pirson, Y., Wen, L.S., Atkinson, J.P. Goodship, T.H.J. (2003) Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome. Proceedings of the National Academy of Sciences of the United States of America, 100, 12966 12971.
61. Rougier, N., Kazatchkine, M.D., Rougier, J.P., Frémeaux-Bacchi, V., Blouin, J., Deschenes, G., Soto, B., Baudouin, V., Pautard, B., Proesmans, W., Weiss, E. Weiss, L. (1998) Human complement factor H deficiency associated with hemolytic uremic syndrome. Journal of the American Society of Nephrology, 9, 2318 2326.
62. Roumenina, L.T., Jablonski, M., Hue, C., Blouin, J., Dimitrov, J.D., Dragon-Durey, M.A., Cayla, M., Fridman, W.H., Macher, M.A., Ribes, D., Moulonguet, L., Rostaing, L., Satchell, S.C., Mathieson, P.W., Sautes-Fridman, C., Loirat, C., Regnier, C.H., Halbwachs-Mecarelli, L. Fremeaux-Bacchi, V. (2009) Hyperfunctional C3 convertase leads to complement deposition on endothelial cells and contributes to atypical hemolytic uremic syndrome. Blood, 114, 2837 2845.
63. Saland, J.M., Emre, S.H., Shneider, B.L., Benchimol, C., Ames, S., Bromberg, J.S., Remuzzi, G., Strain, L. Goodship, T.H. (2006) Favorable long-term outcome after liver-kidney transplant for recurrent hemolytic uremic syndrome associated with a factor H mutation. American Journal of Transplantation, 6, 1948 1952.
64. Saland, J.M., Shneider, B.L., Bromberg, J.S., Shi, P.A., Ward, S.C., Magid, M.S., Benchimol, C., Seikaly, M.G., Emre, S.H., Bresin, E. Remuzzi, G. (2009a) Successful split liver-kidney transplant for factor H associated hemolytic uremic syndrome. Clinical Journal of the American Society of Nephrology, 4, 201 206.
65. Saland, J.M., Ruggenenti, P., Remuzzi, G. the Consensus Study Group (2009b) Liver-kidney transplantation to cure Atypical Hemolytic Uremic Syndrome. Journal of the American Society of Nephrology, 20, 940 949.
66. Sánchez-Corral, P., Pérez-Caballero, D., Huarte, O., Simckes, A.M., Goicoechea, E., López-Trascasa, M. Rodríguez de Córdoba, S. (2002) Structural and functional characterization of factor H mutations associated with atypical hemolytic uremic syndrome. American Journal of Human Genetics, 71, 1285 1295.
67. Sánchez-Corral, P., González-Rubio, C., Rodríguez de Córdoba, S. López-Trascasa, M. (2004) Functional analysis in serum from atypical Hemolytic Uremic Syndrome patients reveals impaired protection of host cells associated with mutations in factor H. Molecular Immunology, 41, 81 84.
68. Saunders, R.E., Abarrategui-Garrido, C., Frémeaux-Bacchi, V., Goicoechea de Jorge, E., Goodship, T.H.J., López-Trascasa, M., Noris, M., Ponce-Castro, I.M., Remuzzi, G., Rodríguez de Córdoba, S., Sánchez-Corral, P., Skerka, C., Zipfel, P.F. Perkins, S.J. (2007) The interactive factor H-atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and factor I mutations with structural models. Human Mutation, 28, 222 234.
69. Sellier-Leclerc, A.L., Fremeaux-Bacchi, V., Dragon-Durey, M.A., Macher, M.A., Niaudet, P., Guest, G., Boudailliez, B., Bouissou, F., Deschenes, G., Gie, S., Tsimaratos, M., Fischbach, M., Morin, D., Nivet, H., Alberti, C. Loirat (2007) Differential impact of complement mutations on clinical characteristics in atypical Hemolytic Uremic Syndrome. Journal of the American Society of Nephrology, 18, 2392 2400.
70. Ståhl, A.L., Vaziri-Sani, F., Heinen, S., Kristoffersson, A.C., Gydell, K.H., Raafat, R., Gutierrez, A., Beringer, O., Zipfel, P.F. Karpman, D. (2008) Factor H dysfunction in patients with atypical hemolytic uremic syndrome contributes to complement deposition on platelets and their activation. Blood, 111, 5307 5315.
71. Ståhl, A.L., Kristoffersson, A., Olin, A.I., Olsson, M.L., Roodhooft, A.M., Proesmans, W. Karpman, D. (2009) A novel mutation in the complement regulator clusterin in recurrent hemolytic uremic syndrome. Molecular Immunology, 46, 2236 2243.
72. Strobel, S., Hoyer, P.F., Mache, C.J., Sulyok, E., Liu, W.S., Richter, H., Oppermann, M., Zipfel, P.F. Józsi, M. (2010) Functional analyses indicate a pathogenic role of factor H autoantibodies in atypical haemolytic uraemic syndrome. Nephrology Dialysis and Transplantation, 25, 136 144.
73. Tawadrous, H., Maga, T., Sharma, J., Kupferman, J., Smith, R.J.H. Schoeneman, M. (2010) A novel mutation in the complement factor B gene (CFB) and atypical hemolytic uremic syndrome. Pediatric Nephrology, 5, 947 951.
74. Taylor, C.M., Machin, S., Wigmore, S.J., Goodship, the British Committee for Standards in Haematology the British Transplantation Society (2010) Clinical practice guidelines for the management of atypical Haemolytice Uraemic Syndrome in the United Kingdom. British Journal of Haematology, 148, 37 47.
75. Thompson, R.A. Winterborn, M.H. (1981) Hypocomplementemia due to a genetic deficiency of β1H globulin. Clinical and Experimental Immunology, 46, 110 119.
76. Tortajada, A., Montes, T., Martínez-Barricarte, R., Morgan, B.P., Harris, C.L. de Córdoba, S.R. (2009) The disease-protective complement factor H allotypic variant Ile62 shows increased binding affinity for C3b and enhanced cofactor activity. Human Molecular Genetics, 18, 3452 3461.
77. Vaziri-Sani, F., Holmberg, L., Sjöholm, A.G., Kristoffersson, A.C., Manea, M., Frémeaux-Bacchi, V., Fehrman-Ekholm, I., Raafat, R. Karpman, D. (2006) Phenotypic expression of factor H mutations in patients with atypical hemolytic uremic syndrome. Kidney International, 69, 981 988.
78. Venables, J.P., Strain, L., Routledge, D., Bourn, D., Powell, H.M., Warwicker, P., Díaz-Torres, M.L., Sampson, A., Mead, P., Webb, M., Pirson, Y., Jackson, M.S., Hughes, A., Wood, K.M., Goodship, J.A. Goodship, T.H.J. (2006) Atypical haemolytic uraemic syndrome associated with a hybrid complement gene. PLoS Medicine, 10, 1957 1967.
79. Walport, M.J. (2001) Complement: first of two parts. New England Journal of Medicine, 344, 1058 1066.
80. Warwicker, P., Goodship, T.H.J., Donne, R.L., Pirson, Y., Nicholls, A., Ward, R.M., Turnpenny, P. Goodship, J.A. (1998) Genetic studies into inherited and sporadic hemolytic uremic syndrome. Kidney International, 53, 836 844.
81. Waters, A.M., Pappworth, I., Marchbank, K., Bockenhauer, D., Tullus, K., Pickering, M.C., Strain, L., Sebire, N., Shroff, R., Marks, S.D., Goodship, T.H. Rees, L. (2010) Successful renal transplantation in factor H autoantibody associated HUS with CFHR1 and 3 deficiency and CFH variant G2850T. American Journal of Transplantation, 10, 168 172.
82. Zimmerhackl, L.B., Hofer, J., Cortina, G., Mark, W., Würzner, R., Jungraithmayr, T.C., Khursigara, G., Kliche, K.O. Radauer, W. (2010) Prophylactic eculizumab after renal transplantation in atypical hemolytic-uremic syndrome. New England Journal of Medicine, 362, 1746 1748.
83. Zipfel, P.F., Edey, M., Heinen, S., Józsi, M., Richter, H., Misselwitz, J., Hoppe, B., Routledge, D., Strain, L., Hughes, A.E., Goodshipe, J.A., Licht, C., Goodship, T.H.J. Skerka, C. (2007) Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical Hemolytic Uremic Syndrome. PLoS Genetics, 3, 387 392.
84. Zipfel, P.F., Mache, C., Müller, D., Licht, C., Wigger, M. Skerka (2010) DEAP-HUS: deficiency of CFHR plasma proteins and autoantibody-positive form of haemolytic uremic syndrome. Pediatric Nephrology, February 16 [Epub ahead of print] PMID: 20157737. DOI:.